330 related articles for article (PubMed ID: 17380076)
1. [Inhibitory effect of angiotensin blockade on hepatic fibrosis in common bile duct-ligated rats].
Park DH; Baik SK; Choi YH; Kim MY; Rhim DW; Kim JW; Kwon SO; Cho MY; Kim CH; Ahn SC
Korean J Hepatol; 2007 Mar; 13(1):61-9. PubMed ID: 17380076
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model.
Kim MY; Baik SK; Park DH; Jang YO; Suk KT; Yea CJ; Lee IY; Kim JW; Kim HS; Kwon SO; Cho MY; Ko SB; Chang SJ; Um SH; Han KH
J Gastroenterol; 2008; 43(11):889-96. PubMed ID: 19012043
[TBL] [Abstract][Full Text] [Related]
3. [Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model].
Kim MY; Baik SK; Jang YO; Suk KT; Kim JW; Kim HS; Cho MY; Choi SJ; Um SH; Han KH
Korean J Hepatol; 2008 Jun; 14(2):159-67. PubMed ID: 18617763
[TBL] [Abstract][Full Text] [Related]
4. Effects of Yinchenhao decoction on self-regulation of renin-angiotensin system by targeting angiotensin converting enzyme 2 in bile duct-ligated rat liver.
Wu L; Zhou PQ; Xie JW; Zhu R; Zhou SC; Wang G; Wu ZX; Hao S
J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):519-524. PubMed ID: 26223920
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.
Lubel JS; Herath CB; Tchongue J; Grace J; Jia Z; Spencer K; Casley D; Crowley P; Sievert W; Burrell LM; Angus PW
Clin Sci (Lond); 2009 Sep; 117(11):375-86. PubMed ID: 19371232
[TBL] [Abstract][Full Text] [Related]
6. Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis.
Tuncer I; Ozbek H; Ugras S; Bayram I
Exp Toxicol Pathol; 2003 Sep; 55(2-3):159-66. PubMed ID: 14620537
[TBL] [Abstract][Full Text] [Related]
7. Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats.
Lee TY; Chang HH; Chen JH; Hsueh ML; Kuo JJ
J Ethnopharmacol; 2007 Jan; 109(2):318-24. PubMed ID: 16989967
[TBL] [Abstract][Full Text] [Related]
8. Effect of Rifaximin on Hepatic Fibrosis in Bile Duct-ligated Rat Model.
Shin SK; Kwon OS; Lee JJ; Park YH; Choi CS; Jeong SH; Choi DJ; Kim YS; Kim JH
Korean J Gastroenterol; 2017 Nov; 70(5):239-246. PubMed ID: 29161793
[TBL] [Abstract][Full Text] [Related]
9. [Prolonged angiotensin-(1-7) infusion inhibits hepatic fibrosis in rats with bile duct ligation].
Li X; Ning Z; Luo W; Zhang W; Yu C
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):944-7. PubMed ID: 22820573
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
Karimian G; Mohammadi-Karakani A; Sotoudeh M; Ghazi-Khansari M; Ghobadi G; Shakiba B
Biomed Pharmacother; 2008 Jun; 62(5):312-6. PubMed ID: 18191530
[TBL] [Abstract][Full Text] [Related]
11. Aqueous extract of Artemisia iwayomogi Kitamura attenuates cholestatic liver fibrosis in a rat model of bile duct ligation.
Han JM; Kim HG; Choi MK; Lee JS; Park HJ; Wang JH; Lee JS; Son SW; Hwang SY; Son CG
Food Chem Toxicol; 2012 Oct; 50(10):3505-13. PubMed ID: 22824087
[TBL] [Abstract][Full Text] [Related]
12. Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats.
Mahmoud MF; Swefy SE; Hasan RA; Ibrahim A
Eur J Pharmacol; 2014 Nov; 742():118-24. PubMed ID: 25179573
[TBL] [Abstract][Full Text] [Related]
13. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the cannabinoid receptors by andrographolide attenuates hepatic apoptosis following bile duct ligation in rats with fibrosis.
Lee TY; Lee KC; Chang HH
Apoptosis; 2010 Aug; 15(8):904-14. PubMed ID: 20446039
[TBL] [Abstract][Full Text] [Related]
15. Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats.
Ueki M; Koda M; Yamamoto S; Matsunaga Y; Murawaki Y
J Gastroenterol; 2006 Oct; 41(10):996-1004. PubMed ID: 17096069
[TBL] [Abstract][Full Text] [Related]
16. Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats.
Ebrahimkhani MR; Kiani S; Oakley F; Kendall T; Shariftabrizi A; Tavangar SM; Moezi L; Payabvash S; Karoon A; Hoseininik H; Mann DA; Moore KP; Mani AR; Dehpour AR
Gut; 2006 Nov; 55(11):1606-16. PubMed ID: 16543289
[TBL] [Abstract][Full Text] [Related]
17. The effects of hyperbaric oxygen application against cholestatic oxidative stress and hepatic damage after bile duct ligation in rats.
Ayvaz S; Kanter M; Aksu B; Sahin SH; Uzun H; Erboga M; Pul M
J Surg Res; 2013 Jul; 183(1):146-55. PubMed ID: 23462455
[TBL] [Abstract][Full Text] [Related]
18. Coffee consumption prevents fibrosis in a rat model that mimics secondary biliary cirrhosis in humans.
Arauz J; Zarco N; Hernández-Aquino E; Galicia-Moreno M; Favari L; Segovia J; Muriel P
Nutr Res; 2017 Apr; 40():65-74. PubMed ID: 28473062
[TBL] [Abstract][Full Text] [Related]
19. Effect of captopril on TNF-α and IL-10 in the livers of bile duct ligated rats.
Amirshahrokhi K; Ghazi-khansari M; Mohammadi-Farani A; Karimian G
Iran J Immunol; 2010 Dec; 7(4):247-51. PubMed ID: 21189448
[TBL] [Abstract][Full Text] [Related]
20. The effects of the selective mineralocorticoid receptor antagonist eplerenone on hepatic fibrosis induced by bile duct ligation in rat.
Matono T; Koda M; Tokunaga S; Sugihara T; Ueki M; Murawaki Y
Int J Mol Med; 2010 Jun; 25(6):875-82. PubMed ID: 20428791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
